Advertisement
YOU ARE HERE: LAT HomeCollectionsVitrasert Drug
IN THE NEWS

Vitrasert Drug

FEATURED ARTICLES
BUSINESS
December 9, 1995 | Times Staff and Wire Reports
FDA Panel OKs Drug for Blindness in Some AIDS Patients: A capsule implanted in the eyes of patients is more than two times better than existing therapy, government scientists agreed. A study reaching that conclusion prompted an advisory panel to the Food and Drug Administration to urge, by a 6-1 vote, that Chiron Vision's Vitrasert implant be approved for sale. Patients undergo a 45-minute outpatient eye surgery to implant the capsule behind their retina; it works for about eight months.
ARTICLES BY DATE
BUSINESS
December 9, 1995 | Times Staff and Wire Reports
FDA Panel OKs Drug for Blindness in Some AIDS Patients: A capsule implanted in the eyes of patients is more than two times better than existing therapy, government scientists agreed. A study reaching that conclusion prompted an advisory panel to the Food and Drug Administration to urge, by a 6-1 vote, that Chiron Vision's Vitrasert implant be approved for sale. Patients undergo a 45-minute outpatient eye surgery to implant the capsule behind their retina; it works for about eight months.
Los Angeles Times Articles
|